CN103028083A - Traditional Chinese medicine for treating benign prostatic hyperplasia - Google Patents
Traditional Chinese medicine for treating benign prostatic hyperplasia Download PDFInfo
- Publication number
- CN103028083A CN103028083A CN2012105125998A CN201210512599A CN103028083A CN 103028083 A CN103028083 A CN 103028083A CN 2012105125998 A CN2012105125998 A CN 2012105125998A CN 201210512599 A CN201210512599 A CN 201210512599A CN 103028083 A CN103028083 A CN 103028083A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- prostatic hyperplasia
- traditional chinese
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating benign prostatic hyperplasia. The traditional Chinese medicine comprises the following components in parts by weight: 3-5 parts of herba epimedii, 10-12 parts of fructus lycii, 10-12 parts of herba ecliptae, 8-10 parts of lily, 10-12 parts of rhizoma anemarrhenae, 10-12 parts of aster striatus, 5-8 parts of rhizoma sparganii, 5-8 parts of rhizoma curcumae, 3-5 parts of semen persicae, 3-5 parts of radix notoginseng, 8-10 parts of radix salviae miltiorrhizae, 8-10 parts of selaginella uncinata, 3-5 parts of radix panacis quinquefolii, 5-8 parts of ludwigia octovalvis, 8-10 parts of fried hovenia dulcis and 10-12 parts of exocarpium benincasae. The traditional Chinese medicine has efficacies of tonifying kidney, softening hard mass, clearing heat and treating stranguria, has good curative effect of treating benign prostatic hyperplasia, is quick in effect and has no any toxic or side effect.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of prostatic hyperplasia.
Background technology
The pathology of prostatic hyperplasia hyperplasia of prostate and analysis pathology prostate divide inside and outside two-layer: internal layer is periurethral mucosa and submucosal gland body; Skin is body of prostate.The latter consists of prostatic main body, has fibrous membrane to separate between two-layer.Prostatic hyperplasia mainly occurs in internal layer, in the gland plastid stroma of neck of bladder urethra to one section of the seminal colliculus, now claim this part be the transitional zone microscopy as seen.The gland plastid stroma has slight hyperplastic tissue, and structure is take the connective tissue of hypertrophy and smooth muscle as main, and there have glandular sac, the hypertrophy glandular tube epithelium of increase to be mamillary to be outstanding in the blister cavities, forms the Combination tuberosity of interstitial gland sample tissue.In recent years, along with expanding economy, compete more and more stronglyer, people's life stress is increasing, and the prostatic hyperplasia sickness rate rises to some extent.The poor effect of existing treatment prostatic hyperplasia has repeatedly more, causes protracted course of disease.
Summary of the invention
The invention discloses a kind of Chinese medicine for the treatment of prostatic hyperplasia, this Chinese medicine has the effect of the kidney invigorating softening the hard mass, clearing heat and freeing strangury, increase immunity, treatment prostatic hyperplasia good effect, and instant effect, without any side effects.
The technical solution used in the present invention is as follows:
A kind of Chinese medicine for the treatment of prostatic hyperplasia, it is characterized in that, be comprised of following component, the weight portion of each component is: Herba Epimedii 3-5, Fructus Lycii 10-12, Herba Ecliptae 10-12, Bulbus Lilii 8-10, Rhizoma Anemarrhenae 10-12, Setaria palmifolia 10-12, rhizoma sparganic 5-8, Rhizoma Curcumae 5-8, Semen Persicae 3-5, Radix Notoginseng 3-5, Radix Salviae Miltiorrhizae 8-10, CUIYUNCAO 8-10, Radix Panacis Quinquefolii 3-5, Herba Ludwigiae Prostratae 5-8, Fructus Aurantii (parched) 8-10, Exocarpium Benincasae 10-12.
The Chinese medicine of described treatment prostatic hyperplasia, it is characterized in that, be comprised of following component, the weight portion of each component is: Herba Epimedii 3, Fructus Lycii 10, Herba Ecliptae 10, Bulbus Lilii 8, the Rhizoma Anemarrhenae 10, Setaria palmifolia 12, rhizoma sparganic 5, Rhizoma Curcumae 8, Semen Persicae 3, Radix Notoginseng 3, Radix Salviae Miltiorrhizae 8, CUIYUNCAO 8, Radix Panacis Quinquefolii 3, Herba Ludwigiae Prostratae 8, Fructus Aurantii (parched) 10, Exocarpium Benincasae 10.
Usage and consumption: every day potion, be decocted in water for oral dose, 1 month is a course for the treatment of, generally takes to get final product 2-3 the course for the treatment of.
Beneficial effect:
Chinese medicine composition of the present invention is used for the treatment of prostatic hyperplasia, and this Chinese medicine has the kidney invigorating softening the hard mass clearing heat and freeing strangury, increases the effect of immunity, blood circulation promoting and blood stasis dispelling, treatment prostatic hyperplasia good effect, and instant effect, without any side effects.
The specific embodiment
A kind of Chinese medicine for the treatment of prostatic hyperplasia is comprised of following component, and the weight of each component (gram) is:
Herba Epimedii 3, Fructus Lycii 10, Herba Ecliptae 10, Bulbus Lilii 8, the Rhizoma Anemarrhenae 10, Setaria palmifolia 12, rhizoma sparganic 5, Rhizoma Curcumae 8, Semen Persicae 3, Radix Notoginseng 3, Radix Salviae Miltiorrhizae 8, CUIYUNCAO 8, Radix Panacis Quinquefolii 3, Herba Ludwigiae Prostratae 8, Fructus Aurantii (parched) 10, Exocarpium Benincasae 10.
Usage and consumption: every day potion, be decocted in water for oral dose, 1 month is a course for the treatment of, generally takes to get final product 2-3 the course for the treatment of.
Model case
Save certain, the man, 45 years old, closely over the past half year, often feel the soreness of waist, urine unclean, nocturia 3-4 time, perineum and lower abdomen expand.Check its light red tongue, white and thin fur is greasy, thready pulse.
Diagnosis: prostatic hyperplasia;
Treatment: take Chinese medicine of the present invention, take 10 days after, its nocturia number of times is reduced to 1-2 time, urine heeltap symptom is clearly better, after continuing to take 1 month, its various bad phenomenon disappearances.
Lee, the man, 50 years old, on April 2nd, 2011, head examined.Frequent micturition, urgent micturition, in dysurea urine heeltap March, nocturia 4-5 time is taken multiple Chinese medicine and western medicine heterodyne.
Diagnosis: prostatic hyperplasia;
Treatment: take Chinese medicine of the present invention, take 15 days after, its nocturia without, dysurea without, urine heeltap symptom is clearly better, after continuing to take 2 months, its various bad phenomenon disappear.
The Wang, the man, 70 years old, on July 2nd, 2011, head examined.Frequent micturition, urgent micturition, dysurea May, nocturia 4-5 time is suffered untold misery, and longly takes multiple Chinese medicine and western medicine heterodyne.
Diagnosis: prostatic hyperplasia;
Treatment: take Chinese medicine of the present invention, take 15 days after, its nocturia is kept to 2 times, dysurea without, urine heeltap symptom is clearly better, after continuing to take 2 months, its various bad phenomenon disappear.
Claims (2)
1. a Chinese medicine for the treatment of prostatic hyperplasia is characterized in that, is comprised of following component, and the weight portion of each component is:
Herba Epimedii 3-5, Fructus Lycii 10-12, Herba Ecliptae 10-12, Bulbus Lilii 8-10, Rhizoma Anemarrhenae 10-12, Setaria palmifolia 10-12, rhizoma sparganic 5-8, Rhizoma Curcumae 5-8, Semen Persicae 3-5, Radix Notoginseng 3-5, Radix Salviae Miltiorrhizae 8-10, CUIYUNCAO 8-10, Radix Panacis Quinquefolii 3-5, Herba Ludwigiae Prostratae 5-8, Fructus Aurantii (parched) 8-10, Exocarpium Benincasae 10-12.
2. the Chinese medicine for the treatment of prostatic hyperplasia according to claim 1, it is characterized in that, be comprised of following component, the weight portion of each component is: Herba Epimedii 3, Fructus Lycii 10, Herba Ecliptae 10, Bulbus Lilii 8, the Rhizoma Anemarrhenae 10, Setaria palmifolia 12, rhizoma sparganic 5, Rhizoma Curcumae 8, Semen Persicae 3, Radix Notoginseng 3, Radix Salviae Miltiorrhizae 8, CUIYUNCAO 8, Radix Panacis Quinquefolii 3, Herba Ludwigiae Prostratae 8, Fructus Aurantii (parched) 10, Exocarpium Benincasae 10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105125998A CN103028083A (en) | 2012-12-05 | 2012-12-05 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105125998A CN103028083A (en) | 2012-12-05 | 2012-12-05 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103028083A true CN103028083A (en) | 2013-04-10 |
Family
ID=48015812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105125998A Pending CN103028083A (en) | 2012-12-05 | 2012-12-05 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103028083A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893447A (en) * | 2014-04-24 | 2014-07-02 | 赵永君 | Medicine for treating prostatitis and preparation method thereof |
| CN105311569A (en) * | 2015-11-19 | 2016-02-10 | 吴斌 | Medicine for treating hyperplasia of prostate gland |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102240370A (en) * | 2011-06-15 | 2011-11-16 | 王少云 | Chinese medicinal composition for treating benign prostatic hyperplasia and preparation method thereof |
-
2012
- 2012-12-05 CN CN2012105125998A patent/CN103028083A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102240370A (en) * | 2011-06-15 | 2011-11-16 | 王少云 | Chinese medicinal composition for treating benign prostatic hyperplasia and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893447A (en) * | 2014-04-24 | 2014-07-02 | 赵永君 | Medicine for treating prostatitis and preparation method thereof |
| CN105311569A (en) * | 2015-11-19 | 2016-02-10 | 吴斌 | Medicine for treating hyperplasia of prostate gland |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101744976A (en) | Sterilizing and antipruritic lotion and preparation method thereof | |
| CN101214357A (en) | Pharmaceutical composition for treating chronic prostatitis | |
| CN102210753B (en) | Traditional Chinese medicine composition for treating lithiasis in urinary system | |
| CN102423423B (en) | Traditional Chinese medicine for treating urinary tract infection | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN103656377B (en) | A kind of Chinese medicine of internal and external application chronic prostatitis | |
| CN103028083A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN104688627A (en) | Acne eliminating mask | |
| CN102049001A (en) | Formula of traditional Chinese medicine for treating primary dysmenorrhea | |
| CN101559187A (en) | Lotion for disinfecting private parts of male and female | |
| CN103948782A (en) | Pharmaceutical composition for treating hyperplasia of mammary glands due to stagnation of liver qi as well as preparation method and application of pharmaceutical composition | |
| CN103989803B (en) | A kind of Chinese medicine treating infertility | |
| CN104208358A (en) | Traditional Chinese medicine for treating renal calculi | |
| CN103990058A (en) | Menstruation promoting and vigor keeping paste | |
| CN103263725A (en) | External application compositions of traditional Chinese medicine for treating urocystitis and external application device thereof | |
| CN103495122B (en) | Traditional Chinese medicine for treating urolithiasis | |
| CN102698053B (en) | Nacre Chinese herbal preparation for relieving depression and preparation method of same | |
| CN103110756B (en) | Traditional Chinese medicine composition for treating renal hematuria | |
| CN103285323B (en) | Traditional Chinese medicine for treating astriction | |
| CN103127460B (en) | Traditional Chinese medicine composition for curing gynecologic inflammation and preparation method thereof | |
| CN102743686B (en) | The scorching clearing capsule of a kind of basin | |
| CN105477431A (en) | Traditional Chinese medicinal composition for treating prostatitis | |
| CN104667026A (en) | Traditional Chinese medicine composition for treating gastrointestinal heat accumulation type constipation | |
| CN103301388B (en) | Traditional Chinese medicine composition for treating chronic gastrointestinal inflammation | |
| CN103877282A (en) | Traditional Chinese medicine preparation for treating salpinx obstructive infertility caused by accumulation and stasis of damp-heat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20130410 |
|
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |